Stay updated on ACCORD Clinical Trial: Alzheimer's Agitation

Sign up to get notified when there's something new on the ACCORD Clinical Trial: Alzheimer's Agitation page.
Latest website image capture
Clouds background image

Latest updates to the ACCORD Clinical Trial: Alzheimer's Agitation page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:57:28.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the context of a double-blind, placebo-controlled, randomized withdrawal trial assessing the efficacy and safety of AXS-05 for the treatment of agitation in subjects with dementia of the Alzheimer's type.
    Difference
    0.1%
    Check dated 2024-06-06T14:44:45.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying the diagnosis requirements for Alzheimer's disease and agitation. Previously, no information was provided about the participation criteria for collaborators and investigators.
    Difference
    10%
    Check dated 2024-05-22T21:23:56.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:33:29.000Z thumbnail image

Stay in the know with updates to ACCORD Clinical Trial: Alzheimer's Agitation

Enter your email address, and we'll notify you when there's something new on the ACCORD Clinical Trial: Alzheimer's Agitation page.